Spear Therapeutics Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4

Spear Therapeutics General Information

Description

Developer of anti-cancer drugs. The company caters to the healthcare industry and specializes in developing prodrugs for the treatment of cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Sardinia House
  • 6th Floor
  • London
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Spear Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Spear Therapeutics‘s full profile, request access.

Request a free trial

Spear Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Gerry Potter Co-Founder
You’re viewing 1 of 2 executive team members. Get the full list »

Spear Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Spear Therapeutics‘s full profile, request access.

Request a free trial